Ventas (NYSE:VTR) Price Target Raised to $93.00

Ventas (NYSE:VTR) had its price objective lifted by JPMorgan Chase & Co. from $88.00 to $93.00 in a report published on Friday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the real estate investment trust’s stock.

Other research analysts have also issued reports about the company. Jefferies Financial Group reiterated a “buy” rating and set a $93.00 target price on shares of Ventas in a report on Monday, December 15th. Argus set a $88.00 price target on Ventas in a report on Tuesday, February 10th. KeyCorp raised their price target on Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Cantor Fitzgerald reiterated an “overweight” rating and set a $93.00 price objective on shares of Ventas in a report on Monday, February 9th. Finally, Weiss Ratings upgraded Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $90.13.

Ventas Stock Down 3.6%

Shares of NYSE:VTR opened at $82.46 on Friday. Ventas has a 52 week low of $60.15 and a 52 week high of $88.36. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67. The company has a market capitalization of $39.17 billion, a PE ratio of 152.70, a PEG ratio of 2.04 and a beta of 0.73. The company has a 50 day moving average price of $82.51 and a two-hundred day moving average price of $77.09.

Ventas (NYSE:VTR) last posted its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The firm had revenue of ($1,229.71) million during the quarter, compared to analyst estimates of $1.53 billion. During the same quarter last year, the business posted $0.81 earnings per share. The company’s revenue for the quarter was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Analysts forecast that Ventas will post 3.4 earnings per share for the current year.

Ventas Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.52 per share. The ex-dividend date is Tuesday, March 31st. This is a positive change from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a yield of 2.5%. Ventas’s dividend payout ratio is currently 385.19%.

Insider Activity at Ventas

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the business’s stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $77.66, for a total transaction of $801,606.52. Following the sale, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. The trade was a 0.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the transaction, the executive vice president owned 72,755 shares of the company’s stock, valued at approximately $6,184,175. This represents a 32.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 86,106 shares of company stock valued at $6,931,397. Corporate insiders own 0.80% of the company’s stock.

Institutional Trading of Ventas

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. NewEdge Advisors LLC increased its position in shares of Ventas by 856.1% during the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after purchasing an additional 7,097 shares during the last quarter. Empowered Funds LLC boosted its holdings in shares of Ventas by 6.8% in the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after buying an additional 536 shares during the last quarter. Woodline Partners LP boosted its holdings in shares of Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after buying an additional 11,739 shares during the last quarter. Focus Partners Wealth grew its stake in shares of Ventas by 130.4% in the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after buying an additional 12,233 shares in the last quarter. Finally, Cetera Investment Advisers grew its stake in shares of Ventas by 3.4% in the second quarter. Cetera Investment Advisers now owns 36,918 shares of the real estate investment trust’s stock valued at $2,331,000 after buying an additional 1,209 shares in the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.